Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01866514 · ClinicalTrials.gov registry record · NA
Proximal Humerus Site for Anesthesia
A NA study of Intraosseous Vascular Access, sponsored by Vidacare Corporation.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01866514 is a NA study of Intraosseous Vascular Access that has completed, run by Vidacare Corporation. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01866514, a NA study of Intraosseous Vascular Access, has completed, sponsored by Vidacare Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a prospective, non-controlled study using healthy adult volunteers as subjects receiving bilateral proximal humerus intraosseous (IO) vascular access to evaluate the insertion technique and IO infusion flow rates.
Conditions Studied
Interventions
- PROCEDURE proximal humerus intraosseous vascular access
- DRUG 2% preservative-free lidocaine
- DEVICE EZ-IO
Study Locations (1)
Texas
- Bulverde-Spring Branch EMS - Spring Branch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01866514
The ClinicalTrials.gov registry entry for NCT01866514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vidacare Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intraosseous Vascular Access appearing as the primary indexed condition, and to 3 interventions - of which proximal humerus intraosseous vascular access is the first listed.
NCT01866514 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01866514 about?
NCT01866514 is a clinical study titled "Proximal Humerus Site for Anesthesia". This will be a prospective, non-controlled study using healthy adult volunteers as subjects receiving bilateral proximal humerus intraosseous (IO) vascular access to evaluate the insertion technique and IO infusion flow rates.
What is the current status of trial NCT01866514?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2013-05. Estimated completion is 2013-06.
What conditions does trial NCT01866514 study?
This clinical trial studies the following conditions: Intraosseous Vascular Access.
What interventions are being tested in trial NCT01866514?
The interventions under investigation include: proximal humerus intraosseous vascular access (PROCEDURE), 2% preservative-free lidocaine (DRUG), EZ-IO (DEVICE).
Who is sponsoring clinical trial NCT01866514?
This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01866514 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraosseous Vascular Access
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.